Schedule 13D ownership disclosure

PRANA BIOTECHNOLOGY LTD SHS (A

Security class unavailable · CUSIP: Q7739U108

Event date: 2020-10-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
269,905,533
Percent of class
19.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-118161
Form type
SC 13D/A
Filer
ALTERITY THERAPEUTICS LTD
CIK
CIK 1131343
Filed
Oct 26, 2020
Reporting period
Oct 23, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub